1 |
WEISSLEDER R. Molecular imaging: Exploring the next frontier[J]. Radiology,1999,212(3):609-614. doi:10.1148/radiology.212.3.r99se18609 .
|
2 |
MANKOFF D A. A definition of molecular ima-ging[J]. J Nucl Med,2007,48(6):18N,21N.
|
3 |
JUDENHOFER M S, WEHRL H F, NEWPORT D F, et al. Simultaneous PET-MRI: A new approach for functional and morphological imaging[J]. Nat Med,2008,14(4):459-465. doi:10.1038/nm1700 .
|
4 |
EHMAN E C, JOHNSON G B, VILLANUEVA-MEYER J E, et al. PET/MRI: Where might it replace PET/CT?[J]. J Magn Reson Imaging,2017,46(5):1247-1262. doi:10.1002/jmri.25711 .
|
5 |
ARABI H, ZAIDI H. Applications of artificial intelligence and deep learning in molecular imaging and radiotherapy[J]. Eur J Hybrid Imaging,2020,4(1):17. doi:10.1186/s41824-020-00086-8 .
|
6 |
吴睿,卢久富,郝亮,等. 分子影像探针[J].化学通报,2019,82(10):886-892. doi:10.14159/j.cnki.0441-3776.2019.10.002 .
|
|
WU R, LU J F, HAO L, et al. Molecular imaging probes[J]. Huaxue Tongbao,2019,82(10):886-892.
|
7 |
SACHPEKIDIS C, BÄUMER P, KOPKA K, et al. 68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer[J]. Eur J Nucl Med Mol Imaging,2018,45(6):904-912. doi:10.1007/s00259-018-3936-0 .
|
8 |
SCHÜTZ L, LOBSIEN D, FRITZSCH D, et al. Feasibility and acceptance of simultaneous amyloid PET/MRI[J]. Eur J Nucl Med Mol Imaging,2016,43(12):2236-2243. doi:10.1007/s00259-016-3462-x .
|
9 |
HATHI D K, JONES E F. 68Ga FAPI PET/CT: Tracer uptake in 28 different kinds of cancer[J]. Radiol Imaging Cancer,2019,1(1):e194003. doi:10.1148/rycan.2019194003 .
|
10 |
TIAN M, HE X, JIN C, et al. Transpathology: Molecular imaging-based pathology[J]. Eur J Nucl Med Mol Imaging,2021,48(8):2338-2350. doi:10.1007/s00259-021-05234-1 .
|
11 |
WANG J, JIN C, ZHOU J, et al. PET molecular imaging for pathophysiological visualization in Alzheimer’s disease[J]. Eur J Nucl Med Mol Imaging,2023,50(3):765-783. doi:10.1007/s00259-022-05999-z .
|
12 |
SAPIENZA D, ASMUNDO A, SILIPIGNI S, et al. Feasibility study of MRI muscles molecular imaging in evaluation of early post-mortem interval[J]. Sci Rep,2020,10(1):392. doi:10.1038/s41598-019-57357-z .
|
13 |
丛斌,齐倩. 法医转化医学模式——法医学发展的新契机[J].中国法医学杂志,2015,30(6):553-555. doi:10.13618/j.issn.1001-5728.2015.06.001 .
|
|
CONG B, QI Q. Forensic translational medicine model: A new opportunity for the forensic science development[J]. Zhongguo Fayixue Zazhi,2015,30(6):553-555.
|
14 |
ABI-DARGHAM A, HORGA G. The search for ima-ging biomarkers in psychiatric disorders[J]. Nat Med,2016,22(11):1248-1255. doi:10.1038/nm.4190 .
|
15 |
BUCHSBAUM M S, MITELMAN S A, CHRISTIAN B T, et al. Four-modality imaging of unmedicated subjects with schizophrenia: 18F-fluorodeoxy-glucose and 18F-fallypride PET, diffusion tensor imaging, and MRI[J]. Psychiatry Res Neuroimaging,2022,320:111428. doi:10.1016/j.pscychresns.2021.111428 .
|
16 |
ERRITZOE D, GODLEWSKA B R, RIZZO G, et al. Brain serotonin release is reduced in patients with depression: A [11C]Cimbi-36 positron emission tomography study with a d-amphetamine challenge[J]. Biol Psychiatry,2023,93(12):1089-1098. doi:10.1016/j.biopsych.2022.10.012 .
|
17 |
HELLWIG S, DOMSCHKE K. Update on PET ima-ging biomarkers in the diagnosis of neuropsychia-tric disorders[J]. Curr Opin Neurol,2019,32(4):539-547. doi:10.1097/WCO.0000000000000705 .
|
18 |
VANO L J, VERONESE M, MCCUTCHEON R A, et al. Neuromelanin-sensitive MRI: A biomarker for treatment-resistant schizophrenia?[J]. Am J Psychiatry,2024,181(6):468-470. doi:10.1176/appi.ajp.20240278 .
|
19 |
KRAGULJAC N V, MCDONALD W M, WIDGE A S, et al. Neuroimaging biomarkers in schizophrenia[J]. Am J Psychiatry,2021,178(6):509-521. doi:10.1176/appi.ajp.2020.20030340 .
|
20 |
HOU H, TIAN M, ZHANG H. Positron emission tomography molecular imaging of dopaminergic system in drug addiction[J]. Anat Rec (Hoboken),2012,295(5):722-733. doi:10.1002/ar.22457 .
|
21 |
VOLKOW N D, FOWLER J S, WANG G J, et al. Imaging dopamine’s role in drug abuse and addiction[J]. Neuropharmacology,2009,56(S1):3-8. doi:10.1016/j.neuropharm.2008.05.022 .
|
22 |
ZHU Y, ZHANG H, TIAN M. Molecular and functional imaging of internet addiction[J]. Biomed Res Int,2015,2015:378675. doi:10.1155/2015/378675 .
|
23 |
LINDAUER R J L, BOOIJ J, HABRAKEN J B A, et al. Cerebral blood flow changes during script-driven imagery in police officers with posttraumatic stress disorder[J]. Biol Psychiatry,2004,56(11):853-861. doi:10.1016/j.biopsych.2004.08.003 .
|
24 |
宋随民,马春玲,李淑瑾,等. 我国设立法医局的必要性及其管理模式[J].中国工程科学,2020,22(4):154-160. doi:10.15302/J-SSCAE-2020.04.022 .
|
|
SONG S M, MA C L, LI S J, et al. Developing medical examiner offices in China: Necessity and administration mode[J]. Zhongguo Gongcheng Kexue,2020,22(4):154-160.
|
25 |
霍宪丹. 关于进一步规范精神疾病司法鉴定执业活动的几点思考[J].中国司法鉴定,2011(5):68-69. doi:10.3969/j.issn.1671-2072.2011.05.018 .
|
|
HUO X D. Thoughts to further regulate the practice of forensic psychiatric appraisal[J]. Zhongguo Sifa Jianding,2011(5):68-69.
|
26 |
CHEN R, CUI Z, CAPITÃO L, et al. Precision biomarkers for mood disorders based on brain ima-ging[J]. BMJ,2020,371:m3618. doi:10.1136/bmj.m3618 .
|
27 |
TIAN M, CHEN Q, ZHANG Y, et al. PET imaging reveals brain functional changes in internet gaming disorder[J]. Eur J Nucl Med Mol Imaging,2014,41(7):1388-1397. doi:10.1007/s00259-014-2708-8 .
|
28 |
WANKHADE T D, INGALE S W, MOHITE P M, et al. Artificial intelligence in forensic medicine and toxicology: The future of forensic medicine[J]. Cureus,2022,14(8):e28376. doi:10.7759/cureus.28376 .
|
29 |
CURRIE G, HAWK K E, ROHREN E. The transformational potential of molecular radiomics[J]. J Med Radiat Sci,2023,70(S2):77-88. doi:10.1002/jmrs.626 .
|
30 |
GONG C, JING C, CHEN X, et al. Generative AI for brain image computing and brain network computing: A review[J]. Front Neurosci,2023,17:1203104. doi:10.3389/fnins.2023.1203104 .
|
31 |
张钦廷,李豪喆,陈琛,等. 法医精神病鉴定内容架构及评定要点解析[J].中国司法鉴定,2020(1):8-20. doi:10.3969/j.issn.1671-2072.2020.01.002 .
|
|
ZHANG Q T, LI H Z, CHEN C, et al. The content frame and assessment point of forensic psychiatry appraisal[J]. Zhongguo Sifa Jianding,2020(1):8-20.
|
32 |
龙江,况伟宏,彭祖贵,等. 新型毒品滥用者大脑神经毒性损害的PET研究[J].中国药物依赖性杂志,2012,21(4):295-298. doi:10.3969/j.issn.1007-9718.2012.04.012 .
|
|
LONG J, KUANG W H, PENG Z G, et al. A study on the brain neurotoxicity of the synthetic drugs by PET[J]. Zhongguo Yaowu Yilaixing Zazhi,2012,21(4):295-298.
|
33 |
CUMMING P, SCHEIDEGGER M, DORNBIERER D, et al. Molecular and functional imaging studies of psychedelic drug action in animals and humans[J]. Molecules,2021,26(9):2451. doi:10.3390/molecules26092451 .
|
34 |
DOS SANTOS R G, OSÓRIO F L, CRIPPA J A S, et al. Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging[J]. Neurosci Biobehav Rev,2016,71:715-728. doi:10.1016/j.neubiorev.2016.10.026 .
|
35 |
NIU X, GAO X, ZHANG M, et al. Meta-analysis of structural and functional brain alterations in internet gaming disorder[J]. Front Psychiatry,2022,13:1029344. doi:10.3389/fpsyt.2022.1029344 .
|
36 |
ROUSSEAU P F, MALBOS E, VERGER A, et al. Increase of precuneus metabolism correlates with reduction of PTSD symptoms after EMDR therapy in military veterans: An 18F-FDG PET study during virtual reality exposure to war[J]. Eur J Nucl Med Mol Imaging,2019,46(9):1817-1821. doi:10.1007/s00259-019-04360-1 .
|
37 |
HASLER B P, INSANA S P, JAMES J A, et al. Evening-type military veterans report worse lifetime posttraumatic stress symptoms and greater brainstem activity across wakefulness and REM sleep[J]. Biol Psychol,2013,94(2):255-262. doi:10.1016/j.biopsycho.2013.06.007 .
|
38 |
HUANG M X, YURGIL K A, ROBB A, et al. Voxel-wise resting-state MEG source magnitude ima-ging study reveals neurocircuitry abnormality in active-duty service members and veterans with PTSD[J]. Neuroimage Clin,2014,5:408-419. doi:10.1016/j.nicl.2014.08.004 .
|
39 |
WILDE E A, BOUIX S, TATE D F, et al. Advanced neuroimaging applied to veterans and service personnel with traumatic brain injury: State of the art and potential benefits[J]. Brain Imaging Behav,2015,9(3):367-402. doi:10.1007/s11682-015-9444-y .
|
40 |
RAMAGE A E, LITZ B T, RESICK P A, et al. Regional cerebral glucose metabolism differentiates danger- and non-danger-based traumas in post-traumatic stress disorder[J]. Soc Cogn Affect Neurosci,2016,11(2):234-242. doi:10.1093/scan/nsv102 .
|
41 |
范政. 警察创伤后应激障碍的影响因素及预防对策研究——以X地公安民警为例[D].北京:中国人民公安大学,2020.
|
|
FAN Z. Study on the influencing factors and preventive measures of police post traumatic stress disorder — Take the police of X as an example[D]. Beijing: People’s Public Security University of China,2020.
|
42 |
侯一平,云利兵,诸虹,等. 我国法医学人才培养发展战略研究[J].中国工程科学,2019,21(2):84-88. doi:10.15302/J-SSCAE-2019.02.009 .
|
|
HOU Y P, YUN L B, ZHU H, et al. Development strategy of talent cultivation for forensic medicine in China[J]. Zhongguo Gongcheng Kexue,2019,21(2):84-88.
|